• Explore /
  • Poster
  • / Genetic polymorphisms of CCL5 and CCR5 to predict efficacy of cetuximab-based treatment in metastatic colorectal cancer patients depending on primary tumor location.

Genetic polymorphisms of CCL5 and CCR5 to predict efficacy of cetuximab-based treatment in metastatic colorectal cancer patients depending on primary tumor location.

Abstract Poster

Authors

null

Mitsukuni Suenaga

Division of Medical Oncology, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA

Mitsukuni Suenaga , Shu Cao , Sebastian Stintzing , Wu Zhang , Dongyun Yang , Yan Ning , Satoshi Okazaki , Martin D. Berger , Yuji Miyamoto , Marta Schirripa , Roel Gopez Jr., Elizabeth Melendez , Shivani Soni , Afsaneh Barzi , Toshiharu Yamaguchi , Volker Heinemann , Heinz-Josef Lenz

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Epidemiology/Outcomes

Citation

J Clin Oncol 35, 2017 (suppl; abstr 3594)

DOI

10.1200/JCO.2017.35.15_suppl.3594

Abstract #

3594

Poster Bd #

217

Abstract Disclosures

Similar Posters

First Author: Francesca Battaglin

First Author: Madiha Naseem

First Author: Madiha Naseem

First Author: Volker Heinemann